Cohort2 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
6. Parkinson disease
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02418598 (ClinicalTrials.gov) | April 14, 2015 | 12/4/2015 | AADC Gene Therapy for Parkinson's Disease | A Phase I /II Study of Intra-putaminal Infusion of Adeno-Associated Virus Encoding Human Aromatic L-Amino Acid Decarboxylase in Subjects With Parkinson's Disease | Parkinson Disease | Genetic: Cohort1;Genetic: Cohort2 | Jichi Medical University | Takara Bio Inc.;Gene Therapy Research Institution,Co.,Ltd. | Terminated | 35 Years | 75 Years | All | 2 | Phase 1/Phase 2 | Japan |